Glaxo Wins Ruling Against Paxil Users
From Bloomberg News
GlaxoSmithKline won a federal court ruling denying class-action status for Paxil users in California who claim the company failed to tell them the antidepressant was habit-forming.
U.S. District Judge Mariana Pfaelzer wrote in an Aug. 29 ruling that the claims were too dissimilar to be tried as a group.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
